Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
04/01/1999 | WO1998024482A3 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
04/01/1999 | DE19741955A1 Mittel gegen bakterielle Meningitis Medicines for bacterial meningitis |
04/01/1999 | CA2820212A1 Recombinant rsv virus expression systems and vaccines |
04/01/1999 | CA2619698A1 Lkta deletion mutant of p. haemolytica |
04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
04/01/1999 | CA2305016A1 Human complement c3-degrading proteinase from streptococcus pneumoniae |
04/01/1999 | CA2304961A1 Methods and compositions for binding hematopoietic stem cells |
04/01/1999 | CA2304932A1 Recombinant rsv virus expression systems and vaccines |
04/01/1999 | CA2304615A1 Agents for combating bacterial meningitis |
04/01/1999 | CA2304599A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
04/01/1999 | CA2304378A1 Cellular immunogenicity potentiating composition containing .alpha.-glycosylceramide |
04/01/1999 | CA2304268A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
04/01/1999 | CA2304244A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines |
04/01/1999 | CA2304129A1 Tie ligand homologues |
04/01/1999 | CA2303405A1 53bp2 complexes |
04/01/1999 | CA2302936A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
04/01/1999 | CA2302867A1 Attenuated respiratory syncytial viruses |
04/01/1999 | CA2302806A1 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor substances, and uses thereof |
04/01/1999 | CA2272605A1 Pharmaceutical composition containing gp34 binding-inhibitory agent as effective ingredient |
04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
03/31/1999 | EP0905251A1 Expression of heterologous protein in yeast |
03/31/1999 | EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
03/31/1999 | EP0905249A2 Alcohol dehydrogenase |
03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
03/31/1999 | EP0905247A2 MurF polynucleotides and polypeptides from Staphylococcus |
03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |
03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
03/31/1999 | EP0905244A2 FolC from Streptococcus |
03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
03/31/1999 | EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily |
03/31/1999 | EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily |
03/31/1999 | EP0905236A1 Transcription factor DP-1 |
03/31/1999 | EP0905233A2 Staphylococcus aureus trigger factor |
03/31/1999 | EP0905140A1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
03/31/1999 | EP0904786A1 Tumor vaccination by the use of antigen transduced autologous cells |
03/31/1999 | EP0904784A1 Probiotic nutritional preparation |
03/31/1999 | EP0904543A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease |
03/31/1999 | EP0904395A1 Herpes simplex virus strains |
03/31/1999 | EP0904394A1 Chicken embryo lethal orphan (celo) virus |
03/31/1999 | EP0904393A1 Parapoxvirus vectors |
03/31/1999 | EP0904380A2 Synthetic hiv genes |
03/31/1999 | EP0904379A2 Simian-human hav having a chimeric 2c protein |
03/31/1999 | EP0904378A1 Hepatitis b monoclonal antibodies |
03/31/1999 | EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides |
03/31/1999 | EP0904365A1 Antigenically reactive regions of the hepatitis-a virus polyprotein |
03/31/1999 | EP0904351A1 Animal cells and processes for the replication of influenza viruses |
03/31/1999 | EP0904292A1 Growth differentiation factor-14 |
03/31/1999 | EP0904288A2 Pathogenic escherichia coli associated protein |
03/31/1999 | EP0904287A2 Cytokine designated lerk-8 |
03/31/1999 | EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE |
03/31/1999 | EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE |
03/31/1999 | EP0904278A1 Apoptosis inducing molecule ii |
03/31/1999 | EP0904277A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
03/31/1999 | EP0904112A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
03/31/1999 | EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE |
03/31/1999 | EP0904107A1 Immunoglobin-like domains with increased half lives |
03/31/1999 | EP0904106A1 Feline vaccines containing chlamydia psittaci and method for making the same |
03/31/1999 | EP0904105A1 Novel compounds |
03/31/1999 | EP0904104A1 Novel compounds |
03/31/1999 | EP0904103A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE GLUTAMYL tRNA SYNTHETASE FAMILY |
03/31/1999 | EP0904100A1 Receptor ligand-facilitated delivery of biologically active molecules |
03/31/1999 | EP0904090A1 Egg anti-inflammatory composition, method of isolation and use |
03/31/1999 | EP0612353B1 Detection method for c-raf-1 genes |
03/31/1999 | EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents |
03/31/1999 | CN1042733C Use of jackfruit seed agglutinin affinity chromatographic column |
03/30/1999 | US5889176 Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences |
03/30/1999 | US5889172 DNA sequences for immunologically active peptides of pertussis toxin |
03/30/1999 | US5889171 Genetic engineered polypeptide |
03/30/1999 | US5889168 Fusion glycoprotein from HCMV and HSV |
03/30/1999 | US5889166 Recombinant neospora antigens and their uses |
03/30/1999 | US5889160 Human IL-2 receptor γ-chain molecule antibody |
03/30/1999 | US5889158 Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens |
03/30/1999 | US5889144 Fused somatotropin epitopic peptides that potentiate growth hormone activity |
03/30/1999 | US5889143 Evaluation and treatment of patients with progressive immunosuppression |
03/30/1999 | US5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds |
03/30/1999 | US5888833 Antigens recognized by antibodies to rheumatoid arthritis, their preparation and their applications |
03/30/1999 | US5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
03/30/1999 | US5888812 Myeloid cell leukemia associated gene MCL-1 |
03/30/1999 | US5888808 Bacterial polypeptide expression employing tryptophan promoter-operator |
03/30/1999 | US5888775 Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof |
03/30/1999 | US5888773 Genetic engineered protein |
03/30/1999 | US5888771 Gene products as targets for the development of antibiotics. |
03/30/1999 | US5888770 Spoiiie |
03/30/1999 | US5888753 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof |
03/30/1999 | US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
03/30/1999 | US5888750 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin |
03/30/1999 | US5888519 Vaccine |
03/30/1999 | US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae |
03/30/1999 | US5888516 Genetic engineered protein |
03/30/1999 | US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host |
03/30/1999 | US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity |
03/30/1999 | US5888511 Treatment of autoimmune diseases, including AIDS |
03/30/1999 | US5888509 Administering antibody |
03/30/1999 | US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore |
03/30/1999 | US5888507 Treatment for insulin dependent diabetes |
03/30/1999 | US5888502 Recombinant retroviruses |
03/30/1999 | CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna |
03/30/1999 | CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein |